Key Points
- Alignment Healthcare President Dawn Christine Maroney sold 30,000 shares on April 15 at an average price of $20.87 for $626,100, executed under a pre-arranged Rule 10b5-1 plan and leaving her with 1,028,813 shares (a 2.83% reduction).
- Maroney has executed multiple sales since mid‑January, totaling roughly 185,862 shares across several transactions, indicating sustained insider selling activity.
- ALHC has a market cap of $4.27 billion, reported quarterly revenue of $1.01 billion (up 44.4% YoY) with EPS of ($0.05) beating estimates, and carries a consensus analyst rating of Moderate Buy with a $24.75 price target.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction dated Wednesday, April 15th. The stock was sold at an average price of $20.87, for a total transaction of $626,100.00. Following the completion of the sale, the president directly owned 1,028,813 shares in the company, valued at approximately $21,471,327.31. This represents a 2.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Dawn Christine Maroney also recently made the following trade(s):
- On Wednesday, March 18th, Dawn Christine Maroney sold 36,749 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.84, for a total transaction of $655,602.16.
- On Monday, March 16th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.48, for a total transaction of $524,400.00.
- On Thursday, March 12th, Dawn Christine Maroney sold 29,113 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.45, for a total transaction of $508,021.85.
- On Tuesday, February 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.63, for a total transaction of $618,900.00.
- On Thursday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $22.48, for a total transaction of $674,400.00.
Alignment Healthcare Stock Performance
Shares of ALHC stock opened at $20.92 on Thursday. The firm has a market cap of $4.27 billion, a price-to-earnings ratio of -2,089.91, a P/E/G ratio of 3.11 and a beta of 1.20. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.71 and a current ratio of 1.71. Alignment Healthcare, Inc. has a 52 week low of $11.63 and a 52 week high of $23.87. The firm's 50-day simple moving average is $19.22 and its two-hundred day simple moving average is $19.11.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.10. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1 billion. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. The company's revenue for the quarter was up 44.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.16) earnings per share. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several analysts have commented on the stock. UBS Group lifted their price objective on shares of Alignment Healthcare from $18.00 to $21.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 14th. Wall Street Zen lowered shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, March 7th. TD Cowen boosted their price target on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a "buy" rating in a research report on Friday, January 16th. Weiss Ratings reissued a "sell (d-)" rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. Finally, JPMorgan Chase & Co. boosted their price target on shares of Alignment Healthcare from $23.00 to $26.00 and gave the company an "overweight" rating in a research report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Alignment Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $24.75.
Read Our Latest Research Report on ALHC
Institutional Trading of Alignment Healthcare
Several hedge funds and other institutional investors have recently modified their holdings of the business. T. Rowe Price Investment Management Inc. raised its position in shares of Alignment Healthcare by 0.6% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company's stock valued at $249,715,000 after purchasing an additional 79,268 shares during the period. Invesco Ltd. raised its position in shares of Alignment Healthcare by 38.9% in the fourth quarter. Invesco Ltd. now owns 6,202,592 shares of the company's stock valued at $122,501,000 after purchasing an additional 1,735,962 shares during the period. Mercer Global Advisors Inc. ADV raised its position in shares of Alignment Healthcare by 6.9% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 15,452 shares of the company's stock valued at $305,000 after purchasing an additional 996 shares during the period. Mackenzie Financial Corp raised its position in shares of Alignment Healthcare by 25.6% in the fourth quarter. Mackenzie Financial Corp now owns 46,917 shares of the company's stock valued at $901,000 after purchasing an additional 9,552 shares during the period. Finally, nVerses Capital LLC bought a new stake in Alignment Healthcare during the 4th quarter worth approximately $396,000. Institutional investors own 86.19% of the company's stock.
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
